Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
Celia Oreja‐Guevara, Bassem Yamout(American University of Beirut Medical Center), Melinda Magyari(University of Copenhagen), Gavin Giovannoni(Queen Mary University of London), Patrick Vermersch(Inserm), Heinz Wiendl(University Medical Center Freiburg), Hashem Salloukh(Harley-Davidson (United States)), Suzanne Hodgkinson(UNSW Sydney), Wallace Brownlee(Multiple Sclerosis Society), Eva Havrdová(Charles University), Elisabeth Gulowsen Celius(Oslo University Hospital), Bart Van Wijmeersch(National MS Center Melsbroek), Diego Centonze(University of Rome Tor Vergata), Daniel Selchen, Christoph Kleinschnitz(Essen University Hospital)
Cited by 44
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
|Journal of Neurology Neurosurgery & Psychiatry|1992|1.8k
Multiple Sclerosis Severity Score
|Neurology|2005|957
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging
|Journal of the Neurological Sciences|1993|930
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706